NBP NovaBridge Biosciences - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jun 16, 2026
$1.36
· of 52w range
· above low
· to high
$1.3152w low
$6.7952w high
Market Cap
$360M
P/E
-6.5
EPS
$-0.21
Revenue
$632.0K
your badges
52W Range
$1–$7
Analyst Rating
BUY
Price Target
$9
P/E
-6.5
ROE
-21.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
NBP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.35
Market Cap
$360M
P/E
-6.5
EPS
$-0.21
Revenue
$632.0K
ROE
-21.4%
52W Range
$1–$7
NBP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$632.0K2017-12-31 → 2023-12-31
EPS$-0.212017-12-31 → 2025-12-31
Free Cash Flow$-21M2019-12-31 → 2025-12-31
Net margin·2019-12-31 → 2023-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -6.55Y avg ≈-7.8 | ≈-7.8 | · | · | |
| P/B | 1.65Y avg ≈1.9 | ≈1.9 | 3.2 | Overvalued | |
| Price / FCF | -17.55Y avg ≈-15.8 | ≈-15.8 | · | · | |
| Price / Cash Flow | -17.55Y avg ≈-15.9 | ≈-15.9 | · | · | |
| Price / Tangible Book | 1.65Y avg ≈7.1 | ≈7.1 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -19.6%5Y avg ≈-27.5% | ≈-27.5% | -55.2% | Top tier | |
| ROE | -21.4%5Y avg ≈-53.6% | ≈-53.6% | -60.0% | Top tier | |
| ROIC | -40.8% | · | -60.0% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 8.15Y avg ≈10.6 | ≈10.6 | 9.2 | Low liquidity | |
| Quick Ratio | 7.85Y avg ≈10.2 | ≈10.2 | 7.8 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$21.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-77.5%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Dec. 31, 2025 | $-0.29 | $-0.05 | -447.2% | |
| Sept. 30, 2025 | $-0.03 | $-0.05 | 37.5% | |
| June 30, 2025 | $-0.07 | $-0.04 | -63.4% | |
| March 31, 2025 | $-0.03 | $-0.07 | 54.3% | |
| Dec. 31, 2024 | $-0.08 | $-0.06 | -39.9% | |
| Sept. 30, 2024 | $-0.25 | $-0.23 | -6.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $632.0K | $-2M | $88M | $1.54B | $30M | $54M | |
| Cost of Revenue | · | · | · | $27M | $46M | $0 | $0 | · | |
| R&D Expense | $63M | $22M | $21M | $23M | $1.21B | $985M | $840M | $426M | |
| SG&A Expense | $31M | $30M | $28M | $29M | $900M | $402M | $655M | $66M | |
| Operating Expenses | $94M | $51M | $73M | $52M | · | · | · | · | |
| Operating Income | $-94M | $-51M | $-72M | $-53M | · | · | · | · | |
| Interest Expense | · | · | $722.0K | $9.0K | $0 | $957.0K | $3M | $12M | |
| Interest Income | $8M | $7M | $9M | $5M | $21M | $24M | $31M | $5M | |
| Other Non-op | $-2M | $-5M | $-8M | $-28M | $83M | $413M | $-20M | $-17M | |
| Pretax Income | $-88M | $-50M | $-82M | $-141M | $-2.33B | $483M | $-1.45B | $-401M | |
| Income Tax | $0 | $0 | $0 | $103.0K | $-3M | $12M | $0 | $2M | |
| Net Income | $-46M | $-22M | $-208M | $-371M | $-2.33B | $471M | $-1.45B | $-403M | |
| EPS (Basic) | $-0.21 | $-0.12 | $-1.09 | $-1.96 | $-13.35 | $3.51 | $-201.19 | $-61.70 | |
| EPS (Diluted) | $-0.21 | $-0.12 | $-1.09 | $-1.96 | $-13.35 | $3.00 | $-201.19 | $-61.70 | |
| Shares (Basic) | 220,258,932 | 186,728,372 | 191,423,850 | 189,787,292 | 174,707,055 | 134,158,824 | 7,381,230 | 6,529,092 | |
| Shares (Diluted) | 220,258,932 | 186,728,372 | 191,423,850 | 189,787,292 | 174,707,055 | 157,231,652 | 7,381,230 | 6,529,092 | |
| EBITDA | $-94M | $-51M | $24M | · | $14M | $13M | $10M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $211M | $68M | $292M | $343M | $3.52B | $4.76B | $1.14B | $1.59B | |
| Short-term Investments | $210.0K | $105M | $20M | $235M | $753M | $32M | $32M | · | |
| Receivables | · | · | · | · | $33M | $130M | · | · | |
| Inventory | · | · | · | · | $27M | $0 | · | · | |
| Prepaid Expense | $7M | $3M | $3M | $80M | $191M | $195M | $136M | $89M | |
| Current Assets | $218M | $177M | $330M | $3.63B | $4.78B | $5.34B | $1.36B | $2.04B | |
| PP&E (Net) | $140.0K | $201.0K | $2M | $61M | $46M | $25M | $30M | $28M | |
| PP&E (Gross) | · | $425.0K | $3M | $116M | $69M | $56M | $48M | $36M | |
| Accum. Depreciation | · | $224.0K | $964.0K | $62M | $44M | $31M | $18M | $8M | |
| Goodwill | · | · | · | $163M | $163M | $163M | $163M | $163M | |
| Intangibles | · | · | $118M | $119M | $120M | $120M | $149M | $149M | |
| Other Non-current Assets | $3M | $1M | $248.0K | $11M | $27M | $2M | $18M | · | |
| Total Assets | $261M | $213M | $369M | $4.07B | $5.60B | $6.33B | $1.74B | $2.38B | |
| Accounts Payable | $17M | $8M | $8M | $707M | $593M | $561M | $274M | $68M | |
| Short-term Debt | · | · | $30M | $19M | · | · | $50M | $80M | |
| Current Liabilities | $27M | $8M | $58M | $758M | $624M | $576M | $588M | $346M | |
| Capital Leases | $2M | $3M | $3M | $32M | $82M | $6M | $7M | · | |
| Other Non-current Liabilities | $511.0K | $0 | $106.0K | $17M | $15M | $9M | · | · | |
| Total Liabilities | $30M | $12M | $126M | $1.16B | $1.04B | $707M | $668M | $416M | |
| Total Debt | · | · | $30M | · | · | · | $50M | · | |
| Common Stock | $27.0K | $19.0K | $19.0K | $132.0K | $126.0K | $114.0K | $6.0K | $6.0K | |
| Retained Earnings | $-1.33B | $-1.29B | $-1.26B | $-6.86B | $-4.35B | $-2.02B | $-2.49B | $-1.01B | |
| Treasury Stock | $5M | $6M | $8M | $21M | · | · | · | $1.0K | |
| AOCI | $42M | $33M | $40M | $214M | $-187M | $-51M | $70M | $59M | |
| Stockholders' Equity | $231M | $201M | $243M | $418M | $715M | $5.63B | $-2.03B | $-955M | |
| Liabilities + Equity | $261M | $213M | $369M | $4.07B | $5.60B | $6.33B | $1.74B | $2.38B | |
| Shares Outstanding | 265,377,891 | 187,452,495 | 185,613,662 | 190,879,919 | 183,826,753 | 164,888,519 | 8,363,719 | 8,363,719 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $300.0K | $500.0K | $200.0K | $14M | $13M | $10M | $7M | |
| Stock-based Comp | $6M | $-2M | $10M | $13M | $609M | $493M | $367M | $4M | |
| Amort. of Intangibles | · | · | $778.0K | $778.0K | $778.0K | $2M | · | · | |
| Other Non-cash | · | $-29M | $-56M | · | $736M | $-544M | $207M | · | |
| Operating Cash Flow | $-21M | $-53M | $-73M | $-50M | $-973M | $434M | $-868M | $-281M | |
| CapEx | $7.0K | $48.0K | $164.0K | $2M | $30M | $8M | $12M | $14M | |
| Investing Cash Flow | · | · | $103M | $458M | $-727M | $-202M | $212M | $10M | |
| Financing Cash Flow | · | · | $8M | $42M | $594M | $3.44B | $153M | $1.48B | |
| Net Change in Cash | $142M | $-242M | $-165M | $-77M | $-1.24B | $3.57B | $-488M | $1.27B | |
| Taxes Paid | $0 | $0 | $0 | $103.0K | $9M | · | · | · | |
| Free Cash Flow | $-21M | $-53M | $-1.32B | · | $-1.00B | $426M | $-880M | · | |
| Levered FCF | · | · | · | · | $-1.00B | $425M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | -5302.0% | · | -2648.7% | 30.5% | -4839.8% | · | |
| Pretax Margin | · | · | -5302.0% | · | -2652.3% | 31.3% | -4839.8% | · | |
| EBITDA Margin | · | · | 86.5% | · | 15.7% | 0.82% | 32.7% | · | |
| ROA | -19.6% | -7.6% | -43.8% | · | -39.1% | 11.7% | -70.6% | · | |
| ROE | -21.4% | -10.0% | -137.2% | · | -45.8% | 26.2% | 97.1% | · | |
| ROIC | -40.8% | -25.6% | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 20.9 | 5.7 | · | 7.7 | 9.3 | 2.3 | · | |
| Quick Ratio | 7.8 | 20.5 | 5.5 | · | 6.9 | 8.5 | 2.0 | · | |
| Debt / Equity | · | · | 0.0 | · | · | · | -0.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | · | 0.0 | 0.4 | 0.0 | · | |
| Inventory Turnover | · | · | · | · | 3.4 | · | · | · | |
| Receivables Turnover | · | · | · | · | 1.1 | 23.6 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.87 | $1.07 | $9.26 | · | $24.80 | $34.13 | $-243.28 | · | |
| Revenue / Share | · | · | $0.14 | · | $0.50 | $9.81 | $4.06 | · | |
| Cash Flow / Share | $-0.09 | $-0.28 | $-6.82 | · | $-5.57 | $2.76 | $-117.59 | · | |
| Cash / Share | $0.79 | $0.36 | $11.54 | · | $19.17 | $28.86 | $136.00 | · | |
| EPS (TTM) | $-0.21 | $-0.12 | $-1.09 | · | $-13.35 | $3.00 | $-201.19 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | $632.0K | · | $88M | $1.54B | $30M | · | |
| Net Income TTM | $-46M | $-22M | $-208M | · | $-2.33B | $471M | $-1.45B | · | |
| Market Cap | $1.06B | $159M | $353M | · | $8.71B | $7.77B | · | · | |
| Enterprise Value | · | · | $-1.90B | · | · | · | · | · | |
| P/E | -19.0 | -7.1 | -1.7 | · | -3.5 | 15.7 | · | · | |
| P/S | · | · | 558.0 | · | 99.0 | 5.0 | · | · | |
| P/B | 4.6 | 0.8 | 0.2 | · | 1.9 | 1.4 | · | · | |
| P / Tangible Book | 4.6 | 0.8 | 2.8 | · | 20.1 | 1.5 | · | · | |
| P / Cash Flow | -51.3 | -3.0 | -0.3 | · | -9.0 | 17.9 | · | · | |
| P / FCF | -51.3 | -3.0 | -0.3 | · | -8.7 | 18.3 | · | · | |
| EV / EBITDA | · | · | -79.6 | · | · | · | · | · | |
| EV / FCF | · | · | 1.4 | · | · | · | · | · | |
| EV / Revenue | · | · | -3009.5 | · | · | · | · | · | |
| Earnings Yield | -5.3% | -14.1% | -57.4% | · | -28.2% | 6.4% | · | · |
Per Share
| Metric | Trend | Q4 2025 | Q4 2022 |
|---|---|---|---|
| EPS (TTM) | $-0.21 | $-1.96 |
Valuation (TTM)
| Metric | Trend | Q4 2025 | Q4 2022 |
|---|---|---|---|
| Revenue TTM | · | $-2M | |
| Net Income TTM | $-46M | $-371M | |
| P/E | -19.0 | -2.1 | |
| Earnings Yield | -5.3% | -46.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | $632.0K | $-2M | $88M |
| Net Income | $-46M | $-22M | $-208M | $-371M | $-2.33B |
| Diluted EPS | $-0.21 | $-0.12 | $-1.09 | $-1.96 | $-13.35 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | 0.0 | · | · |
| Current Ratio | 8.1 | 20.9 | 5.7 | · | 7.7 |
| Quick Ratio | 7.8 | 20.5 | 5.5 | · | 6.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-21M | $-53M | $-1.32B | · | $-1.00B |
Institutional owners (13F) 52 filers · $65.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
52
Value held
$65.0M
New positions
15
Exited positions
11
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 15 (+6 vs prior Q) | 11 (-6 vs prior Q) | 12 (-2 vs prior Q) | 11 (-4 vs prior Q) | -4.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $14,810,156 | 6,032,650 | 22.77% | Shares |
| HHLR ADVISORS, LTD. | $11,662,108 | 5,980,568 | 17.93% | Shares |
| MORGAN STANLEY | $7,123,795 | 3,653,228 | 10.95% | Shares |
| AIHC Capital Management Ltd | $5,612,164 | 2,878,033 | 8.63% | Shares |
| Siren, L.L.C. | $3,909,241 | 2,004,739 | 6.01% | Shares |
| MARSHALL WACE, LLP | $2,402,292 | 1,231,946 | 3.69% | Shares |
| Candriam S.C.A. | $2,206,373 | 1,132,563 | 3.39% | Shares |
| S.A.C. Capital Advisors (Hong Kong) Ltd. | $2,121,963 | 561,366 | 3.26% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1,950,000 | 1,000,000 | 3.00% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,660,129 | 851,348 | 2.55% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,478,541 | 758,226 | 2.27% | Shares |
| BlackRock, Inc. | $1,338,105 | 686,208 | 2.06% | Shares |
| CITADEL ADVISORS LLC | $1,214,520 | 622,831 | 1.87% | Shares |
| E Fund Management Co., Ltd. | $1,148,589 | 589,020 | 1.77% | Shares |
| Exome Asset Management LLC | $1,125,072 | 576,960 | 1.73% | Shares |
| STATE STREET CORP | $702,733 | 360,376 | 1.08% | Shares |
| Woodline Partners LP | $682,500 | 350,000 | 1.05% | Shares |
| Fiera Capital Corp | $615,578 | 315,681 | 0.95% | Shares |
| UBS Group AG | $588,471 | 301,780 | 0.90% | Shares |
| BARCLAYS PLC | $544,087 | 279,019 | 0.84% | Shares |
| Taikang Asset Management (Hong Kong) Co Ltd | $333,315 | 170,931 | 0.51% | Shares |
| GOLDMAN SACHS GROUP INC | $314,576 | 161,321 | 0.48% | Shares |
| ALPS ADVISORS INC | $228,337 | 117,096 | 0.35% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $226,864 | 116,341 | 0.35% | Shares |
| JPMORGAN CHASE & CO | $161,481 | 81,556 | 0.25% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $134,255 | 68,849 | 0.21% | Shares |
| Headlands Technologies LLC | $127,107 | 65,183 | 0.20% | Shares |
| Invesco Ltd. | $122,626 | 62,885 | 0.19% | Shares |
| CITADEL ADVISORS LLC | $67,665 | 34,700 | 0.10% | Call option |
| Caitong International Asset Management Co., Ltd | $59,048 | 30,281 | 0.09% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $56,230 | 28,836 | 0.09% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55,651 | 28,539 | 0.09% | Shares |
| Squarepoint Ops LLC | $51,613 | 26,468 | 0.08% | Shares |
| JANE STREET GROUP, LLC | $35,769 | 18,343 | 0.05% | Shares |
| China Universal Asset Management Co., Ltd. | $34,835 | 17,864 | 0.05% | Shares |
| TWO SIGMA SECURITIES, LLC | $30,500 | 15,641 | 0.05% | Shares |
| Aigen Investment Management, LP | $22,281 | 11,426 | 0.03% | Shares |
| Bronte Capital Management Pty Ltd. | $21,824 | 11,192 | 0.03% | Shares |
| Freestone Capital Holdings, LLC | $19,500 | 10,000 | 0.03% | Shares |
| Mirae Asset Global Investments Co., Ltd. | $9,789 | 5,020 | 0.02% | Shares |
| Tower Research Capital LLC (TRC) | $8,436 | 4,326 | 0.01% | Shares |
| CITIGROUP INC | $5,246 | 2,690 | 0.01% | Shares |
| GF FUND MANAGEMENT CO. LTD. | $4,635 | 2,377 | 0.01% | Shares |
| PNC Financial Services Group, Inc. | $3,900 | 2,000 | 0.01% | Shares |
| SIMPLEX TRADING, LLC | $3,835 | 1,967 | 0.01% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $1,811 | 1,104 | 0.00% | Shares |
| GROUP ONE TRADING LLC | $279 | 143 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $146 | 75 | 0.00% | Shares |
| SG Americas Securities, LLC | $74 | 38,198 | 0.00% | Shares |
| RHUMBLINE ADVISERS | $64 | 33 | 0.00% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| CBC Investment I-Mab Limited, IBC Investment Seven Limited, CBC SPVII LIMITED, C-Bridge II Investment Ten Limited, Nova Aqua Limited, C-Bridge Healthcare Fund II, L.P., C-Bridge Healthcare Fund GP II, L.P., C-Bridge Capital GP, Ltd., I-Bridge Healthcare Fund, L.P., I-Bridge Healthcare GP, L.P., I-Bridge Capital GP, Ltd., Wei Fu ×3 filings | Feb. 3, 2026 | 0.00% | Amendment | · | SEC |
| Everest Medicines Limited | Aug. 5, 2025 | 16.10% | Initial filing | Passive investment | SEC |
| T INVESTMENT LIMITED | Dec. 1, 2023 | · | Initial filing | Passive investment | SEC |
| HHLR Advisors, Ltd., Hillhouse Investment Management, Ltd. ×2 filings | June 30, 2023 | · | Initial filing | · | SEC |
| Hillhouse Capital Advisors, Ltd., Hillhouse Capital Management, Ltd. ×4 filings | June 24, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 8 insiders · 6 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Srishti Gupta | Chief Executive Officer | July 6, 2026 A | · | 0 | 0 | $0 |
| Phillip Andrew Dennis | Chief Medical Officer | Sept. 17, 2026 M | 173,427 | 0 | 2 | $-11,434 |
| Sean Wuxiong Cao | Chief Bus. Development Officer | Sept. 9, 2026 S | 266,467 | 0 | 2 | $-122,488 |
| Cong Claire Xu | EVP, Clinical Development | Aug. 30, 2026 M | 304,201 | 0 | 3 | $-20,351 |
| Mark Arnold Hagler | Chief Commercial Officer | July 8, 2026 A | 230,000 | 1 | 0 | $577,300 |
| Liwei Lorraine Lin | General Counsel | July 8, 2026 A | · | 0 | 0 | $0 |
| Robert A. Lenz | Director | Aug. 22, 2026 M | 17,218 | 0 | 0 | $0 |
| Wei Fu | Director | June 29, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
NBP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$9.00
+564.2%
3 37.5%
Strong Buy
4 50.0%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-30Mean target $9.00 +564.2%
Low$9.00
Mean$9.00
High$9.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Jun 16, 2026